Astellas

Astellas is a top pharmaceutical company based in Tokyo, Japan

Astellas is a top pharmaceutical company based in Tokyo, Japan.Astellas was formed on 1 April, 2005 through the merger of Yamanouchi Pharmaceutical Co., Ltd. and Fujisawa Pharmaceutical Co. Ltd in a ‘merger of equals’ agreement.

Astellas is engaged in the discovery, development, manufacture and sale of pharmaceutical products worldwide.

Report: Partnering Deals and Alliances with Astellas

Astellas is a top pharmaceutical company based in Tokyo, Japan.

Astellas was formed on 1 April, 2005 through the merger of Yamanouchi Pharmaceutical Co., Ltd. and Fujisawa Pharmaceutical Co. Ltd in a ‘merger of equals’ agreement.

Astellas is engaged in the discovery, development, manufacture and sale of pharmaceutical products worldwide.

The company focuses primarily on six key therapy areas, all dedicated on advancing innovations that provide better options and outcomes, enabling healthier lives:

  • Transplantation
  • Urology
  • Oncology
  • Anti infectives
  • Pain management
  • Dermatology

Astellas is one of the largest prescription drug companies in Japan, the company's main products include organ transplant immunosuppressant Prograf, overactive bladder treatment Vesicare, hypertension therapy Micardis, prostate enlargement treatment Harnal, and cholesterol drug Lipitor (sold in Japan via an agreement with Pfizer).

Astellas has an active licensing venture investment and acquisition group charged with analysing and managing all incoming opportunities. Astellas has a long history of partnering, building numerous collaborative partnerships more

Astellas announced over 106 partnering / licensing deals since 2005, with over 15 deals in 2012 alone. Analysis of the partnering deals shows a strong emphasis on partnerships in CNS, diabetes, metabolic disease, infectious diseases followed by oncology, pain management and transplantation more

Astellas has also announced 3 M&A deals since 2005, with the lead deals being the acquisition of OSI pharmaceuticals more

Report: Partnering Deals and Alliances with Astellas

Examples of recent partnering and licensing deals announced by Astellas can be viewed in Current Partnering's Partnering Agreements with Astellas 2005-2013 review article.

Our report provides more detailed insight into the details of each deal. See: Partnering Deals and Alliances with Astellas

Available reports from Current Partnering

Report: Partnering Deals and Alliances with Astellas

Report: Partnering Deals and Alliances with Big Pharma

 

Available resources for deal coverage for Astellas

Subscribe: Current Agreements life sciences partnering, M&A and financing deals database – find out more

Read: more on Astellas company profile, recent partnering, M&A and financing news and articles

 

Related

Report: Practical Guide to Finding Partners

View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value

View: Current Partnering’s M&A Scorecard – view top life science M&A deals by value

View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making

View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity

Signup: Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now

Signup: Current Agreements Deals Review – monthly newsletter - reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now

View: Top 50 pharma – overview of top 50 pharmaceutical companies by revenue – partnering activity, deal news, partnering dealtalk

View: Top 50 biotech – overview of top 50 biotechnology companies by revenue – partnering activity, deal news, partnering dealtalk

Print Friendly, PDF & Email